Dr. Ryan Scott Hays, MD

Dr. Hays practices at James W Aston Ambulatory Care Center in Dallas, Texas.

Dr. Hays' NPI, 1871756809, was assigned on July 9, 2008. Dr. Hays graduated from Texas A&M College of Medicine - Bryan in 2004. Dr. Hays holds Texas license N9453.

Dr. Hays' primary practice is James W Aston Ambulatory Care Center, at 5303 Harry Hines Blvd, Dallas, TX 75390 in Dallas County. The practice phone is (214) 645-2300.

Dr. Hays' primary practice is James W Aston Ambulatory Care Center in Dallas, Texas. Dr. Hays is also affiliated with William P. Clements Jr. University Hospital. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Hays to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hays practices, 3 sites in all. Vendor and product names are available with a free account.

Epilepsy is Dr. Hays' primary specialty in the NPI Registry, under taxonomy code 2084E0001X. Dr. Hays is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Hays' licenses on file in 3 states: Texas, Illinois and Pennsylvania.

Dmand AI lists epilepsy, non-alzheimer's dementia (chronic) and seizures among the conditions Dr. Hays treats.

CMS data shows 355 Medicare services from Dr. Hays across 4 procedure codes in 2024, for 207 Medicare patients. Medicare paid $52,884 for them.

CMS counts 207 Medicare patients who saw Dr. Hays in 2024. The largest group is 65 to 74, with 91 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hays' median patient age at 48, with 58% women.

In 2024, Dr. Hays wrote 312 Medicare Part D claims for 70 patients. 89% of them were for generic drugs. CMS names the drug for 197 of them, across 9 drugs with 11 or more claims each, at $212,956 in total drug cost. In 2023, CMS named 200 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Hays for performance year 2024, reported as part of a group. Dr. Hays accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hays as offering telehealth.

Dmand AI links 43 papers to Dr. Hays, published from 2015 to 2025. 2021 was the busiest year, with 8. The most frequent topics are Epilepsy, Seizures and Electroencephalography. Dr. Hays has published most often in Epilepsy Behav. Dr. Hays' most frequent co-authors are Kan Ding, MD, Mark Andrew Agostini, MD and Ghazala Perven, MD.

CMS Open Payments shows 32 general payments to Dr. Hays from 6 drug and device companies from 2016 to 2019. Food and beverage make up the largest share, 100% of the total. Sunovion Pharmaceuticals Inc. paid the most, $336.

Dmand AI lists 1 award for Dr. Hays, most recently CMS Stage 1 EHR in 2012.

Dr. Hays graduated from Texas A&M College of Medicine - Bryan in 2004. Dr. Hays is a member of AAN, AASM, American Clinical Neurophysiology Society, AES, Sleep Research Society and SHM.

Dr. Hays is in network with 22 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.